Literature DB >> 22927527

Making genuine progress against metastatic breast cancer.

Gary H Lyman1, Harold J Burstein, Aman U Buzdar, Ralph D'Agostino, Paul A Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22927527     DOI： 10.1200/JCO.2012.43.6931

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Pharmacogenomics of breast cancer therapy: an update.

Authors:  Kelly Westbrook; Vered Stearns
Journal:  Pharmacol Ther       Date:  2013-03-13       Impact factor: 12.310

2.  Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Authors:  Issam Makhoul; Valentina K Todorova; Eric R Siegel; Stephen W Erickson; Ishwori Dhakal; Vinay R Raj; Jeannette Y Lee; Mohammed S Orloff; Robert J Griffin; Ronda S Henry-Tillman; Suzanne Klimberg; Laura F Hutchins; Susan A Kadlubar
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.